Turning Point Therapeutics initiates Ph1b/2 combination study

Clinical Impact

Aug 16

Written By Frances Benson

https://www.tptherapeutics.com/news-releases/news-release-details/turning-point-therapeutics-initiates-trident-2-clinical-study

2021

Frances Benson

eFFECTOR Therapeutics debuts as public company

BioTheryX appoints three new members to its Board of Directors